| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
polycystin 1, transient receptor potential channel interacting | 0.493 | 0.769 | 1.00 |
|
group | 0.900 | definitive | 0.976 | 1 | 0 | 1990 | 2019 | ||||||||
|
ankyrin repeat and sterile alpha motif domain containing 6 | 0.682 | 0.346 | 6.9E-06 |
|
group | 0.320 | None | 1.000 | 2 | 0 | 2005 | 2015 | ||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
group | 0.270 | None | 0.875 | 1 | 0 | 2006 | 2019 | ||||||||
|
histone deacetylase 6 | 0.465 | 0.846 | 1.00 |
|
group | 0.240 | None | 1.000 | 1 | 0 | 2014 | 2018 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
group | 0.210 | None | 1.000 | 1 | 0 | 2007 | 2019 | ||||||||
|
angiotensinogen | 0.367 | 0.923 | 5.0E-08 |
|
group | 0.210 | None | 1.000 | 1 | 0 | 2010 | 2019 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
group | 0.210 | None | 1.000 | 1 | 0 | 1996 | 2010 | ||||||||
|
LDL receptor related protein 5 | 0.485 | 0.846 | 0.51 |
|
group | 0.210 | None | 1.000 | 1 | 0 | 2016 | 2019 | ||||||||
|
hypoxia inducible factor 1 subunit alpha | 0.327 | 0.923 | 0.98 |
|
group | 0.210 | None | 0.500 | 1 | 0 | 2007 | 2018 | ||||||||
|
phospholipase A2 group IVA | 0.496 | 0.846 | 6.0E-05 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
phospholipase C gamma 1 | 0.564 | 0.692 | 7.9E-05 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
peroxisome proliferator activated receptor gamma | 0.358 | 0.885 | 2.9E-02 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
prostaglandin-endoperoxide synthase 1 | 0.460 | 0.885 | 6.2E-07 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
solute carrier family 34 member 1 | 0.619 | 0.423 | 8.9E-27 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2000 | 2000 | ||||||||
|
complement C9 | 0.619 | 0.692 | 1.6E-24 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
complement factor B | 0.532 | 0.769 | 4.7E-16 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
secreted phosphoprotein 1 | 0.353 | 0.885 | 2.1E-06 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
bone gamma-carboxyglutamate protein | 0.462 | 0.846 | 4.6E-08 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
superoxide dismutase 1 | 0.379 | 0.962 | 0.18 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
ribosomal protein S6 kinase B1 | 0.511 | 0.731 | 0.97 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
paired like homeodomain 2 | 0.489 | 0.808 | 0.98 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
cyclin dependent kinase inhibitor 1A | 0.403 | 0.769 | 1.9E-03 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
cathepsin B | 0.457 | 0.846 | 5.9E-11 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 1996 | 1996 | ||||||||
|
cathepsin H | 0.626 | 0.654 | 1.3E-08 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 1996 | 1996 | ||||||||
|
G protein-coupled bile acid receptor 1 | 0.548 | 0.731 | 1.4E-09 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2017 | 2017 |